Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Kenvue

Tracked across 15 events · 252 articles · First seen Sep 22, 2025 · Last active Aug 21, 2026

Sentiment
-12
Attention
6
Events
15
Relationships
12
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -60
Regulatory
Impact: Kenvue, a spin-off of Johnson & Johnson, is a primary defendant in the United States — Texas lawsuit, accused of deceptively marketing Tylenol and facing claims of liability transfer from Johnson & Johnson. Kenvue's shares fell following the news.
Oct 28, 2025 · 20 articles
6 70
Business
Impact: Kenvue is being acquired by Kimberly-Clark for $48.7 billion, providing a significant premium to its shareholders. Kenvue's stock surged after the announcement, despite facing scrutiny over Tylenol and activist investor pressure.
Nov 03, 2025 · 10 articles
4 -30
Regulatory
Impact: Primary defendant; faces revived lawsuits alleging failure to warn about autism/ADHD risk. Stock fell 1% on ruling.
Jul 13, 2026 · 23 articles
6 -70
Domestic
Impact: Kenvue, the maker of Tylenol, disputed any link between the drug and autism. Its shares fell 7.5% in trading, reducing its market value by about $2.6 billion due to Donald Trump's statements.
Sep 22, 2025 · 6 articles
6 -60
Business
Impact: Kenvue, formerly Johnson & Johnson's consumer health unit, retained responsibility for talc-related litigation outside the United States and Canada after its spin-off in 2023. It is named as a defendant in the UK lawsuit and maintains that its talc products are safe and asbestos-free.
Oct 16, 2025 · 14 articles
2 -20
Regulatory
Impact: Kenvue Brands, the parent company of Johnson & Johnson — Neutrogena, issued the recall for the contaminated wipes, facing potential financial and reputational consequences.
Oct 24, 2025 · 9 articles
6 -50
Domestic
Impact: Kenvue, the manufacturer of Tylenol, strongly disagreed with the suggestion that acetaminophen causes autism, defending the drug's safety and warning of risks from untreated fever or pain.
Sep 22, 2025 · 6 articles
2 -20
Domestic
Impact: Kenvue, the manufacturer of Tylenol, refuted the claims made by Robert F. Kennedy Jr. and Donald Trump, stating that studies have found no causal link between acetaminophen use during pregnancy and fetal developmental issues.
Oct 09, 2025 · 9 articles
4 20
Tech
Impact: Kenvue, the manufacturer of Tylenol (paracetamol), faced a lawsuit regarding alleged links between its product and autism, which was dismissed. The new study supports the safety of its product.
Jan 16, 2026 · 23 articles
4 30
Business
Impact: Kenvue partnered with Greyparrot to improve recycling for its packaging, using Deepnest to validate performance.
Jul 28, 2026 · 6 articles
4 10
Business
Impact: Kenvue is the target of Kimberly-Clark's roughly $40 billion acquisition, expected to close by year-end. The acquisition is part of Kimberly-Clark's strategy, though the China disruption may affect the deal's timing or financing.
Aug 04, 2026 · 6 articles
2 0
Business
Colgate-Palmolive (India) Limited announced a leadership transition on August 21, 2026. Shar Narasimhan, who served as Managing Director and CEO since 2022, has been elevated to Executive Vice President - Marketing, MSCI Asia Pacific Index…
Impact: Anandani's previous employer; loses its India MD but no direct impact on Kenvue.
Jul 20, 2026 · 24 articles
3 0
Business
Impact: Amit Banati previously served as Chief Financial Officer of Kenvue, Inc. before rejoining Mondelez International.
Jun 15, 2026 · 7 articles
6 0
Business
Impact: Kenvue, J&J's former consumer health business, holds liability for Johnson's baby powder outside North America but is not directly involved in the U.S. settlement.
Jul 27, 2026 · 82 articles
6 0
Business
Dec 23, 2025 · 7 articles
American College of Obstetricians and Gynecologists advocacy beneficiary Kenvue Kenvue benefits from the American College of Obstetricians and Gynecologists' co
American College of Obstetricians and Gynecologists scientific advocate Kenvue The American College of Obstetricians and Gynecologists publicly maintains that
Donald Trump Kenvue
Donald Trump Kenvue
ERGEN INTELLIGENCE
Track Kenvue live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.